Reassessing the emphasis on limited options in antiretroviral treatment
- PMID: 38416552
- DOI: 10.1097/QAD.0000000000003757
Reassessing the emphasis on limited options in antiretroviral treatment
Comment on
-
Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes.AIDS. 2024 Mar 15;38(4):497-508. doi: 10.1097/QAD.0000000000003798. Epub 2023 Dec 8. AIDS. 2024. PMID: 38079588
References
-
- Lucas GM, Gallant JE, Moore RD. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing . AIDS 2004; 18:1539–1548.
-
- Hogg RS, Bangsberg DR, Lima VD, Alexander C, Bonner S, Yip B, et al. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART . PLoS Med 2006; 3:e356.
-
- Zaccarelli M, Forbici F, Lorenzini P, Ceccherini-Silberstein F, Tozzi V, Trotta MP, et al. Continuous evidence of fast HIV disease progression related to class-wide resistance to antiretroviral drugs: a 6-year follow-up analysis of a large observational database . AIDS 2007; 21:1824–1826.
-
- Mocroft A, Pelchen-Matthews A, Hoy J, Llibre JM, Neesgaard B, Jaschinski N, et al. Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes . AIDS 2024; 38:497–508.
-
- Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem AV, et al. ATHENA observational cohort. Future challenges for clinical care of an ageing population infected with HIV: a modelling study . Lancet Infect Dis 2015; 15:810–818.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical